No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients
**Background:** A recent study estimated that more than 1.5 million Americans have an indeterminate pulmonary nodule (IPN) identified on a chest computed tomography (CT) scan each year outside of lung cancer screening programs. However, the cost and pattern of subsequent IPN workup have not been des...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2019-05-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/9674 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860313215205376 |
|---|---|
| author | Bruce S. Pyenson Carol M. Bazell Michael J. Bellanich Melissa A. Caplen Javier J. Zulueta |
| author_facet | Bruce S. Pyenson Carol M. Bazell Michael J. Bellanich Melissa A. Caplen Javier J. Zulueta |
| author_sort | Bruce S. Pyenson |
| collection | DOAJ |
| description | **Background:** A recent study estimated that more than 1.5 million Americans have an indeterminate pulmonary nodule (IPN) identified on a chest computed tomography (CT) scan each year outside of lung cancer screening programs. However, the cost and pattern of subsequent IPN workup have not been described for real-world settings.
**Objectives:** To examine the pattern and cost of IPN workup in real-world practice using insurer administrative claims data for commercially-insured individuals.
**Methods:** The primary source for this retrospective observational study was the MarketScan® 2013-2016 databases, which include information on 28 to 47 million insured lives. The newly diagnosed IPN study population consisted of members with an IPN diagnosis code on a claim in 2014 who did not have prior diagnosis of an IPN or lung cancer in 2013 and who had coverage from 2014 to 2016. Subsequent claims were examined for workups included in the American College of Chest Physicians (ACCP) guideline recommendations and the costs of workup were tabulated.
**Results:** Of the 15 064 patients in the study population, only 5471 (36%) received any subsequent workup. The average and median costs of workup for these patients were $3270 and $2068, respectively. Spread across the commercially-insured population, the workup is estimated to cost between $1 and $2 per member per year.
**Conclusions:** The majority of commercially-insured members with newly identified IPNs do not appear to have any guideline-recommended workup, despite a low incremental cost of such workup services on a population basis. |
| format | Article |
| id | doaj-art-dc75c159cd5f4cf5b228714a723115a6 |
| institution | Kabale University |
| issn | 2327-2236 |
| language | English |
| publishDate | 2019-05-01 |
| publisher | Columbia Data Analytics, LLC |
| record_format | Article |
| series | Journal of Health Economics and Outcomes Research |
| spelling | doaj-art-dc75c159cd5f4cf5b228714a723115a62025-02-10T16:13:06ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362019-05-0163No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured PatientsBruce S. PyensonCarol M. BazellMichael J. BellanichMelissa A. CaplenJavier J. Zulueta**Background:** A recent study estimated that more than 1.5 million Americans have an indeterminate pulmonary nodule (IPN) identified on a chest computed tomography (CT) scan each year outside of lung cancer screening programs. However, the cost and pattern of subsequent IPN workup have not been described for real-world settings. **Objectives:** To examine the pattern and cost of IPN workup in real-world practice using insurer administrative claims data for commercially-insured individuals. **Methods:** The primary source for this retrospective observational study was the MarketScan® 2013-2016 databases, which include information on 28 to 47 million insured lives. The newly diagnosed IPN study population consisted of members with an IPN diagnosis code on a claim in 2014 who did not have prior diagnosis of an IPN or lung cancer in 2013 and who had coverage from 2014 to 2016. Subsequent claims were examined for workups included in the American College of Chest Physicians (ACCP) guideline recommendations and the costs of workup were tabulated. **Results:** Of the 15 064 patients in the study population, only 5471 (36%) received any subsequent workup. The average and median costs of workup for these patients were $3270 and $2068, respectively. Spread across the commercially-insured population, the workup is estimated to cost between $1 and $2 per member per year. **Conclusions:** The majority of commercially-insured members with newly identified IPNs do not appear to have any guideline-recommended workup, despite a low incremental cost of such workup services on a population basis.https://doi.org/10.36469/9674 |
| spellingShingle | Bruce S. Pyenson Carol M. Bazell Michael J. Bellanich Melissa A. Caplen Javier J. Zulueta No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients Journal of Health Economics and Outcomes Research |
| title | No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients |
| title_full | No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients |
| title_fullStr | No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients |
| title_full_unstemmed | No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients |
| title_short | No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients |
| title_sort | no apparent workup for most new indeterminate pulmonary nodules in us commercially insured patients |
| url | https://doi.org/10.36469/9674 |
| work_keys_str_mv | AT brucespyenson noapparentworkupformostnewindeterminatepulmonarynodulesinuscommerciallyinsuredpatients AT carolmbazell noapparentworkupformostnewindeterminatepulmonarynodulesinuscommerciallyinsuredpatients AT michaeljbellanich noapparentworkupformostnewindeterminatepulmonarynodulesinuscommerciallyinsuredpatients AT melissaacaplen noapparentworkupformostnewindeterminatepulmonarynodulesinuscommerciallyinsuredpatients AT javierjzulueta noapparentworkupformostnewindeterminatepulmonarynodulesinuscommerciallyinsuredpatients |